Cargando…
Lipase regulation of cellular fatty acid homeostasis as a Parkinson’s disease therapeutic strategy
Synucleinopathy (Parkinson’s disease (PD); Lewy body dementia) disease-modifying treatments represent a huge unmet medical need. Although the PD-causing protein α-synuclein (αS) interacts with lipids and fatty acids (FA) physiologically and pathologically, targeting FA homeostasis for therapeutics i...
Autores principales: | Fanning, Saranna, Cirka, Haley, Thies, Jennifer L., Jeong, Jooyoung, Niemi, Sarah M., Yoon, Joon, Ho, Gary P. H., Pacheco, Julian A., Dettmer, Ulf, Liu, Lei, Clish, Clary B., Hodgetts, Kevin J., Hutchinson, John N., Muratore, Christina R., Caldwell, Guy A., Caldwell, Kim A., Selkoe, Dennis |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9184586/ https://www.ncbi.nlm.nih.gov/pubmed/35680956 http://dx.doi.org/10.1038/s41531-022-00335-6 |
Ejemplares similares
-
Parkinson’s disease: proteinopathy or lipidopathy?
por: Fanning, Saranna, et al.
Publicado: (2020) -
A Stearoyl–Coenzyme A Desaturase Inhibitor Prevents Multiple Parkinson Disease Phenotypes in α‐Synuclein Mice
por: Nuber, Silke, et al.
Publicado: (2020) -
Lipotoxicity Downstream of α-Synuclein Imbalance: A Relevant Pathomechanism in Synucleinopathies?
por: Tripathi, Arati, et al.
Publicado: (2021) -
Excess membrane binding of monomeric alpha-, beta- and gamma-synuclein is invariably associated with inclusion formation and toxicity
por: Kim, Tae-Eun, et al.
Publicado: (2021) -
Rapid Alpha-Synuclein Toxicity in a Neural Cell Model and Its Rescue by a Stearoyl-CoA Desaturase Inhibitor
por: Terry-Kantor, Elizabeth, et al.
Publicado: (2020)